Zohar Tadmor-Eilat - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Role: Chief People Officer
Signature: /s/ Zohar Tadmor-Eilat
Issuer symbol: CLBT
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 08:28:11 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tadmor-Eilat Zohar	Chief People Officer	94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL	/s/ Zohar Tadmor-Eilat	18 Mar 2026	0001970909

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLBT	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")						129,814	18 Mar 2026	Direct	F1, F2, F3, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLBT	Stock options							18 Mar 2026	Ordinary Shares	22,722	$4.95	Direct	F6
holding	CLBT	Stock options							18 Mar 2026	Ordinary Shares	28,236	$11.51	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 21,988 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on February 14, 2023, of which 5,497 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
F2	Includes 15,615 Ordinary Shares that are represented by RSUs that were granted on March 20, 2024, of which 1,735 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.
F3	Includes 11,760 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 980 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.
F4	Includes 3,471 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through March 20, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.
F5	Includes 39,491 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 9,875 vest on the first anniversary of the grant date and 2,468 vest every three months thereafter through February 10, 2030.
F6	Of these stock options, 7,574 are fully vested and exercisable and 3,787 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027.
F7	Of these stock options, 12,360 are fully vested and exercisable and 1,764 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.